April 14- U.S. drugstore chain operator Walgreen Co is under pressure from a group of shareholders to consider relocating to Europe to gain tax benefits, the Financial Times reported.» Read More
Dec 19- Rite Aid Corp, the third-largest U.S. drugstore chain, cut its full-year profit forecast, mainly due to Medicare reimbursement cuts and higher cost of some generic drugs, sending the company's shares down as much as 11 percent. Rite Aid cut its full-year profit forecast to 17- 23 cents per share from 18- 27 cents per share.
CNBC's Sara Eisen reports GlaxoSmithKline is becoming the first to stop paying doctors to promote drugs.
Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10- year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market.
Dec 10- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc said on Tuesday they would form the largest U.S. generic drug sourcing operation in a 10- year agreement to serve the world's biggest market for generic drugs. The 50-50 joint venture will be operational as soon as July 1, 2014.
Muddled by inconsistent earnings and stock performances, one sector appears tougher and tougher to predict, CNBC's Jim Cramer says.
*Ontario ban could be imitated by other provinces. Pharmacy companies saw the private-label drugs as a way to reduce the impact of Ontario regulations designed to lower the cost of generic drugs. The Ontario rules have weighed on the earnings of the drugstore chains, including Shoppers Drug Mart Corp, a principal appellant in this case.
A medical marijuana dispensary in Central City, Colo.—a small gambling town nestled in the mountains near Denver—just became the first business in the United States licensed to sell marijuana to patrons without a note from their doctors.
Amazon.com is clashing with Johnson & Johnson amid complaints the online retailer hasn't stopped sales of damaged or expired products.
Nov 5- CVS Caremark Corp raised its profit forecast for the year on Tuesday, as sales grew at its drugstore chain and it processed more prescriptions from new clients. Wall Street analysts expected $31.53 billion, according to Thomson Reuters I/B/E/S.
Nov 5- CVS Caremark Corp posted higher quarterly profit and raised its forecast for the year on Tuesday, as sales grew at its drugstore chain and it processed more prescriptions.
Francois Nader, NPS Pharmaceuticals president & CEO, discusses its lead product Gattex for "short bowel syndrome," the potential for Netpara and the solid performance of its stock.
The so-called "pot mom" Andrea Sanderlin has confessed to a judge she operated a facility in which she and others grew at least 1,000 marijuana plants and sold the products. CNBC's Andrea Day has the details.
Drugstores signed on to help educate consumers about Obamacare, but they have their sights set on the future business of these newly insured consumers.
L'Oreal's rumored buyback of Nestle's 29.5 percent stake in the French cosmetics giant looked far from a done deal on Friday, with Jean-Paul Agon, chairman and CEO of L'Oreal, telling CNBC that the ball was in the Swiss food giant's court.
The Department of Justice will not block state marijuana laws if distribution is regulated, reports CNBC's Eamon Javers.
FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.
Washington will tax pot anywhere from 25 to 50 percent at the production and processor level, another 25 percent at retail. CNBC's Jane Wells reports Washington says it could raise up to $2 billion in pot taxes over five years.
CNBC's Jane Wells reports from the River Rock Wellness Center in Denver, Colorado, where in 5 months legal medical cannabis will be able to be sold as recreational pot. Investors are hoping to cash in on the "green rush," she says.
The global coffee market has been rather decaffeinated for the past couple of years, with prices falling to less than half their 2011 peak and the bean becoming the worst-performing soft commodity last year.
NBC's Steve Handelsman reports the U.S. has 25 percent of the world's prisoners; and Joseph diGenova, Former U.S. Attorney, and Matt Welch, Reason Magazine, discuss a drug policy overhaul. "The science of marijuana is very bad," says diGenova, adding "that doesn't mean we should lock people up forever who use it."